Factors Associated with Infection Recurrence After Two-stage Exchange for Periprosthetic Hip Infection

Overview

Journal Int Orthop

Specialty Orthopedics

Date 2022 Feb 7

PMID 35129644

Authors

Fabian Schwolow

Bernd Fuchtmeier

Franz Muller

Affiliations

Soon will be listed here.

Abstract

Purpose: Two-stage exchange is the treatment of choice for periprosthetic joint infection (PJI). Factors and outcomes associated with infection recurrence for hip PJI are limited. The primary aim of this study was to determine factors associated with infection recurrence after two-stage exchange. Secondary aims were survival, mobility, and the EuroQol five-dimension scale (EQ-5D-5L) health state.

Methods: We retrospectively investigated patients with two-stage exchange for hip PJI at our institution from 2006 to 2017. Follow-up was conducted for a minimum of four years after the reimplantation.

Results: We included 135 patients with 139 hip PJIs. The mean age of the patients was 69.6 years (range 32-88). The infection recurrence rate was 14.4% (n = 20) after a mean follow-up of 8.0 years (range 4.0-13.1). Four factors for recurrence were identified at the time of the first stage: previous orthopaedic diagnoses (p < 0.001), type of explanted prosthesis (p = 0.004), cultured microorganisms (p = 0.033), and sinus tract (p = 0.035). A longer surgical reimplantation time (p = 0.015) was the only one factor found at the second stage. The estimated Kaplan-Meier survival for the total sample was 9.0 years (95% confidence interval 8.3-9.8), without significant difference for those with infection recurrence compared to recurrence-free patients (log-rank 0.931). At the time of follow-up, 89 patients were alive. For these patients, Parker mobility score (p = 0.102), EuroQol five-dimensional scale (p = 0.099), and EQ Visual Analogue Scale (EQ-VAS) (p = 0.027) were inferior in those with infection recurrence, but significance was found only for VAS.

Conclusion: In this study with mid- to long-term follow-up, five factors for infection recurrence were identified. Recurrence did not affect survival, but health-related quality of life was inferior compared to recurrence-free patients. The results suggest that the period of the first stage including previous orthopaedic diagnoses requires more consideration in the future.

Citing Articles

Identifying potential predictive indicators for reimplantation timing in two-stage revision: a meta-analysis and system review.

Zhang Q, Li H, Xie H, Liu L, Chen L, Zeng Y Arch Orthop Trauma Surg. 2024; 145(1):88.

PMID: 39714508 DOI: 10.1007/s00402-024-05689-5.

Debridement, antibiotics and implant retention for prosthetic joint infection: comparison of outcomes between total hip arthroplasty and hip resurfacing.

Castanet E, Martinot P, Dartus J, Senneville E, Migaud H, Girard J Int Orthop. 2022; 46(12):2799-2806.

PMID: 35960343 DOI: 10.1007/s00264-022-05522-x.

References

Zimmerli W, Trampuz A, Ochsner P . Prosthetic-joint infections. N Engl J Med. 2004; 351(16):1645-54. DOI: 10.1056/NEJMra040181. View

Charette R, Melnic C . Two-Stage Revision Arthroplasty for the Treatment of Prosthetic Joint Infection. Curr Rev Musculoskelet Med. 2018; 11(3):332-340. PMC: 6105480. DOI: 10.1007/s12178-018-9495-y. View

Ford A, Holzmeister A, Rees H, Belich P . Characterization of Outcomes of 2-Stage Exchange Arthroplasty in the Treatment of Prosthetic Joint Infections. J Arthroplasty. 2018; 33(7S):S224-S227. DOI: 10.1016/j.arth.2018.02.043. View

Engesaeter L, Dale H, Schrama J, Hallan G, Lie S . Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register. Acta Orthop. 2011; 82(5):530-7. PMC: 3242948. DOI: 10.3109/17453674.2011.623572. View

Poulsen N, Mechlenburg I, Soballe K, Lange J . Patient-reported quality of life and hip function after 2-stage revision of chronic periprosthetic hip joint infection: a cross-sectional study. Hip Int. 2017; 28(4):407-414. DOI: 10.5301/hipint.5000584. View

Kunutsor S, Whitehouse M, Blom A, Beswick A . Re-Infection Outcomes following One- and Two-Stage Surgical Revision of Infected Hip Prosthesis: A Systematic Review and Meta-Analysis. PLoS One. 2015; 10(9):e0139166. PMC: 4583275. DOI: 10.1371/journal.pone.0139166. View

Gramlich Y, Hagebusch P, Faul P, Klug A, Walter G, Hoffmann R . Two-stage hip revision arthroplasty for periprosthetic joint infection without the use of spacer or cemented implants. Int Orthop. 2019; 43(11):2457-2466. DOI: 10.1007/s00264-019-04297-y. View

Lee J, Kang C, Lee J, Joung M, Moon S, Wi Y . Risk factors for treatment failure in patients with prosthetic joint infections. J Hosp Infect. 2010; 75(4):273-6. View

Lange J, Troelsen A, Soballe K . Chronic Periprosthetic Hip Joint Infection. A Retrospective, Observational Study on the Treatment Strategy and Prognosis in 130 Non-Selected Patients. PLoS One. 2016; 11(9):e0163457. PMC: 5033335. DOI: 10.1371/journal.pone.0163457. View

10.

Rezaie A, Goswami K, Shohat N, Tokarski A, White A, Parvizi J . Time to Reimplantation: Waiting Longer Confers No Added Benefit. J Arthroplasty. 2018; 33(6):1850-1854. DOI: 10.1016/j.arth.2018.01.073. View

11.

Petis S, Abdel M, Perry K, Mabry T, Hanssen A, Berry D . Long-Term Results of a 2-Stage Exchange Protocol for Periprosthetic Joint Infection Following Total Hip Arthroplasty in 164 Hips. J Bone Joint Surg Am. 2019; 101(1):74-84. DOI: 10.2106/JBJS.17.01103. View

12.

Burastero G, Alessio-Mazzola M, Cavagnaro L, Chiarlone F, Carrega G, Capello A . Conservative two-stage revision with primary components of infected total hip arthroplasty: An analysis of survival, clinical and radiographic outcomes. PLoS One. 2020; 15(10):e0239981. PMC: 7529346. DOI: 10.1371/journal.pone.0239981. View

13.

Parvizi J, Zmistowski B, Berbari E, Bauer T, Springer B, Della Valle C . New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011; 469(11):2992-4. PMC: 3183178. DOI: 10.1007/s11999-011-2102-9. View

14.

Garvin K, Hanssen A . Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am. 1995; 77(10):1576-88. DOI: 10.2106/00004623-199510000-00015. View

15.

Parker M, Palmer C . A new mobility score for predicting mortality after hip fracture. J Bone Joint Surg Br. 1993; 75(5):797-8. DOI: 10.1302/0301-620X.75B5.8376443. View

16.

Ludwig K, von der Schulenburg J, Greiner W . German Value Set for the EQ-5D-5L. Pharmacoeconomics. 2018; 36(6):663-674. PMC: 5954069. DOI: 10.1007/s40273-018-0615-8. View

17.

Triantafyllopoulos G, Memtsoudis S, Zhang W, Ma Y, Sculco T, Poultsides L . Periprosthetic Infection Recurrence After 2-Stage Exchange Arthroplasty: Failure or Fate?. J Arthroplasty. 2016; 32(2):526-531. DOI: 10.1016/j.arth.2016.08.002. View

18.

van Diemen M, Colen S, Dalemans A, Stuyck J, Mulier M . Two-stage revision of an infected total hip arthroplasty: a follow-up of 136 patients. Hip Int. 2013; 23(5):445-50. DOI: 10.5301/hipint.5000049. View

19.

Sanchez-Sotelo J, Berry D, Hanssen A, Cabanela M . Midterm to long-term followup of staged reimplantation for infected hip arthroplasty. Clin Orthop Relat Res. 2008; 467(1):219-24. PMC: 2600996. DOI: 10.1007/s11999-008-0480-4. View

20.

Sharma H, de Leeuw J, Rowley D . Girdlestone resection arthroplasty following failed surgical procedures. Int Orthop. 2005; 29(2):92-5. PMC: 3474513. DOI: 10.1007/s00264-004-0633-3. View